 |
 |
|
|
February 19, 1999
7 a.m.-8:30 a.m.
Industry-Supported Symposia
IS30. Part I: Novel Approaches to the Treatment of Impulsivity Supported by Solvay Pharmaceuticals Inc.
A. Novel Approaches to the Treatment of Pathological Gambling Eric Hollander, M.D.
B. New Treatment Findings in Compulsive Shopping and Sex Addictions Donald W. Black, M.D.
C. The Relationship Between OCD and Impulsivity Joseph Zohar, M.D.
IS31. Part I: Mood and Psychotic Disorders in Women: An Update on Treatment Supported by Eli Lilly and Company
A. Effects of Gonadal Steroids on Brain and Behavior David R. Rubinow, M.D.
B. Mood and Psychotic Disorders in Women During the Childbearing Years Lee S. Cohen, M.D.
C. Course and Treatment of Bipolar Illness During Pregnancy and the Postpartum Period Adele C. Viguera, M.D.
IS32. Part I: Anxiety Disorders: From Scientific Research to Clinical Practice Supported by U.S. Pharmaceuticals, Pfizer Inc.
A. Recognition and Prevention of Anxiety in Children and Adolescents John S. March, M.D.
B. Panic Disorder: Initial Treatment Strategies and Beyond Mark H. Pollack, M.D.
C. Management Strategies for PTSD Kathleen T. Brady, M.D.
IS33. Part I: Assessment and Treatment of Psychiatric Disorders in the Elderly Supported by Janssen Pharmaceutica and Research Foundation
A. Advances in the Treatment of Agitation in the Elderly Stuart C. Yudofsky, M.D
B. Treating Psychiatric Disorders in the Nursing Home George T. Grossberg, M.D.
IS34. Part I: Advances in the Treatment of Geriatric Depression Supported by SmithKline Beecham Pharmaceuticals
A. Pharmacology of Antidepressants Pertinent to Older Patients Bruce G. Pollock, M.D.
B. Treating Severe Melancholic Depression: New Data Benoit H. Mulsant, M.D.
C. Treating Depression in the Oldest-Old: Findings From the Harvard/HRCA Study Carl Salzman, M.D.
7:30 a.m.-6 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 75-80
9 a.m.-10:30 a.m.
Clinical Case Conference 3. Teresa A. Rummans, M.D., on Refractory Depression and ECT (Open to APA members only.)
Discussion Groups
6. Herbert D. Kleber, M.D., on Treatment of Addictions: Myths and Realities
7. James W. Lomax II, M.D., on Spiritual Issues for Psychodynamic Psychiatry (Open to residents only.)
Lectures
L14. Quo Vadis Psychiatry G. Alan Stoudemire, M.D., APA’s Seymour D. Vestermark Award Lecture
L15. To Be Announced Caleb Carr
Master Educator Clinical Consultations
10. Nada L. Stotland, M.D., on The Depressed Woman (Open to APA members only.)
11. John M. Oldham, M.D., on Integrated Treatment of BPD (Open to APA members only.)
New Research Oral/Slide Sessions
Component Workshops
CW35. Current Issues on Abuse and Misuse of Psychiatry APA Committee on International Abuse of Psychiatry and Psychiatrists Chairperson: Jose E. De La Gandara, M.D.
CW36. Executive Roles for Psychiatrists in the 21st Century APA Committee on Psychiatric Administration and Management Chairperson: Philip E. Veenhuis, M.D.
CW37. Funding Managed Care and Public Psychiatric Service Today APA Consortium on Funding for Services Chairperson: Arthur T. Meyerson, M.D.
CW38. Outpatient Detoxification Treatment Services APA Committee on Treatment Services for Addicted Patients Chairperson: Joseph A. Virzi, M.D.
CW39. Culturally Competent Care of Lesbian, Gay, Bisexual, and Transgendered Patients APA Northern California Psychiatric Society’s Committee on Lesbian, Gay, Bisexual, and Transgender Issues Chairperson: Dan H. Karasic, M.D.
Issue Workshops
IW34. Sildenafil Citrate: A Sex Therapist’s Perspective Chairperson: Richard Kogan, M.D.
IW35. The U.S. Health Care Financing Administration Report: Compliance in the Resident Outpatient Clinic Chairperson: Sherri Hansen-Grant, M.D.
IW36. The Mid-Career Clinician: Choices and Challenges Chairperson: Julie K. Pease, M.D.
IW37. Residents Conducting Psychodynamic Psychotherapy Chairperson: Leah J. Dickstein, M.D.
IW38. Clinical Aspects of HIV and AIDS Among Hispanics Chairperson: Pedro Ruiz, M.D.
IW39. Coping With Malpractice Chairperson: Kenneth C. Olson, M.D.
IW40. Teaching Brief Therapy in a Managed Care Clinic Chairperson: Nancy B. Kaltreider, M.D.
IW41. SPECT Imaging: Clinical Application for Diagnosis Co-Chairpersons: Malcolm D. Roberts, M.D., and Thomas Yuschok, M.D.
IW42. Ethical Boundaries in Alternative Therapies Co-Chairpersons: Antoinette W. Jakobi, M.D., and Lisa M. Rosica, D.O.
IW43. The Use of Spirituality Groups in Psychiatric Treatment Chairperson: Nalini V. Juthani, M.D.
IW44. Models of Psychiatric Care for Native Communities Co-Chairpersons: Cornelia Wieman, M.D., and Gary A. Chaimowitz, M.D.
IW45. Violence Denied Begets More Violence Co-Chairpersons: Levon Z. Boyajian, M.D., and Haikaz M. Grigorian, M.D.
IW46. Medical School Response to Student Suicide Chairperson: Donald A. Misch, M.D.
IW47. Clinical and Forensic Aspects of Sexual Harassment Chairperson: Malkah T. Notman, M.D.
9 a.m.-11 a.m.
Media Sessions
Session 21. Integrative Medicine: Implications for Psychiatry
37. Alternative Medicine
38. Body and Soul
Session 22. Treatment Algorithms and Practice Management
39. Algorithm for the Pharmacotherapy of Schizophrenia
40. Booting Up Your Practice
Session 23. The Story of Adele H: A Study of Obsessive and Unrequited Love
41. The Story of Adele H.
9 a.m.-Noon
AIDS Education Program
Part II: Psychiatric and Clinical Manifestations APA Commission on AIDS
A. Mood Disorders and HIV Disease Stephen J. Ferrando, M.D.
B. Psychosis and HIV Disease Francine Cournos, M.D.
C. Somatic Symptoms and Their Psychotherapeutic Implications Marshall Forstein, M.D.
Social Security Workshop
Disability Evaluation Under Social Security Social Security Administration, APA Office of Quality Improvement and Psychiatric Services, and APA Consortium on Organized Service Systems Chairperson: Jerome E. Shapiro, M.D.
9 a.m.-12:30 p.m.
Review of Psychiatry, Part IV: Disruptive Disorders in Children Chairperson: Robert L. Hendren, D.O.
16. ADHD Timothy E. Wilens, M.D.
17. Conduct Disorder Hans Steiner, M.D.
18. Oppositional Defiant Disorder Joseph M. Rey, M.D.
19. Substance Abuse and Disruptive Behavior Disorders Paula D. Riggs, M.D.
20. Violence and Mental Disorders in Youth Jerry M. Wiener, M.D.
9 a.m.-4 p.m.
CME Courses 81-86
10 a.m.-3 p.m.
Exhibits Open (last day)
Publishers’ Bookfair Open (last day)
APA Resource Center Open (last day)
11 a.m.-2 p.m.
Media Session
Session 24. Homosexuality: From Homophobic Prejudice to Gay/Lesbian Understanding
42. Kamikaze Summer
43. Pride Divide
11 a.m.-Noon
Media Sessions
Session 25. Ask the Experts About Computers and Your Practice
11 a.m.-12:30 p.m.
Session 26. Psychodrama and Therapeutic Education
44. Behind the Mask: Teaching Spontaneous Theater
Discussion Group
8. Francisco Fernandez, M.D., on Challenges in HIV Care for Psychiatrists
Lectures
L16. To Be Announced Mary Jane England, M.D., APA’s Alexandra Symonds Award Lecture
L17. Framing and Reframing Battered Women in Mental Health Settings: New Approaches to Understanding and Treatment Evan Stark, Ph.D., Frontiers of Science Lecture Series
Master Educator Clinical Consultations
12. Robert Michels, M.D., on Psychodynamic Psychotherapy (Open to APA members only.)
13. Thomas N. Wise, M.D., on Consultation-Liaison Psychiatry (Open to APA members only.)
Medical Update
3. To Be Announced
Research Consultation With
2. Jeffrey A. Lieberman, M.D., on Scientific, Methodological, and Ethical Issues in Schizophrenia Research
Scientific and Clinical Report Sessions
Session 17. Depression and Suicide in Schizophrenia
50. Life Events Trigger Depression in Early Schizophrenia Joseph Ventura, Ph.D.
51. National Collaborative Study of Early Psychosis and Suicide: An Introduction Ioline D. Henter, M.A.
52. Clinical Correlates of Insight in Psychotic Disorders Giovanni B. Cassano, M.D.
Session 18. Psychiatric Issues in the Public Health Arena
53. What the States Are Doing to Provide Services to Families of Adults With Severe Mental Illness Lisa B. Dixon, M.D.
54. The Effects of Education About Depression in Primary Care Christopher
Thompson, M.D.
55. The Association Between Psychiatric Comorbidity and Retention in a Sample of Women Attending Comprehensive Addiction Treatment Catherine A. Nageotte, M.D.
Session 19. Screening and Treatment of Substance Abuse
56. Enhancing Treatment of Cocaine-Dependent Mothers Joseph R. Volpicelli, M.D.
57. Naltrexone Plus Cognitive-Behavior Therapy for Alcoholism Raymond F. Anton, M.D.
58. The Drug Abuse Screening Test for Adolescents Steve Martino, Ph.D.
Session 20. New Issues in Diagnosis and Treatment of Anxiety Disorders
59. Integrated Therapy of Panic Disorder: A Controlled Study Gabriella Ba, M.D.
60. Long-Term Antidepressant Treatment of Panic/Agoraphobia Matig R. Mavissakalian, M.D.
61. Recognition and Management of a Subgroup of OCD and Tic Disorders Susan E. Swedo, M.D.
Session 21. Race and Gender Sensitivity in the Treatment of Psychiatric Disorders
62. The Rationale for Women-Centered Programming: Gender Differences in the Utilization of Intensive Outpatient Treatment Joseph A. Flaherty, M.D.
63. Therapist/Patient Race and Sex Matching Edward Gottheil, M.D.
64. Recognition of Psychiatric Distress in Low-Income Asian and Latino Primary Care Patients Henry Chung, M.D.
Session 22. Socio-Economic Factors in the Management of Depression
65. Use of Antidepressants in a National Sample Benjamin G. Druss, M.D.
66. Prime-MD Screening: Relevance for Minor Depression Marijo B. Tamburrino, M.D.
67. Socioeconomic Deprivation and Depression Prevalence Kevin Ostler
Session 23. Neonatal and Childhood Exposure to Psychotropics
68. Psychotropic Medication Trends in Preschoolers Julie M. Zito, Ph.D.
69. Neonatal Outcome Associated With Lithium Use During Pregnancy Adele C. Viguera, M.D.
70. Maternal Use of Psychotropics During Lactation: Quantifying Infant Exposure Lee S. Cohen, M.D.
Session 24. Axis II Comorbidity
71. Axis II Comorbidity With BPD in Adolescents Daniel F. Becker, M.D.
72. Axis I Comorbidity With DSM-IV Axis II Disorders Thomas H. McGlashan, M.D.
73. Comorbidity Among Patients With DSM-IV Personality Disorders Carlos M. Grilo, Ph.D.
Session 25. New Horizons in Depression
74. Diagnostic Stability of MDD John W. Goethe, M.D.
75. Methylfolate As an Adjunct in SSRI Refractory Depression Jonathan E. Alpert, M.D.
76. Brain Function and the Placebo Response Andrew F. Leuchter, M.D.
Component Workshops
CW40. Examining Global Psychiatrists’ Training Curricula APA Committee on International Education Co-Chairpersons: Winston W. Shen, M.D., and Michael J. Napoliello, M.D.
CW41. Current and Future Trends in the Assessment and Diagnosis of Infants, Toddlers, and Pre-Schoolers APA Committee on Pre-School Children Co-Chairpersons: Harry H. Wright, M.D., and Kyle D. Pruett, M.D.
CW42. Ethical Challenges in Risk-Based Contracting APA Committee on Managed Care Co-Chairpersons: Barry F. Chaitin, M.D., and Joanne H. Ritvo, M.D.
CW43. Disability in Mental Disorders for Psychiatrists APA Committee on Psychiatric Diagnosis and Assessment Co-Chairpersons: Frederick G. Guggenheim, M.D., and Bedirhan Ustun, M.D.
Issue Workshops
IW48. Clinician-Educator Track in Residency Training Chairperson: Michael D. Jibson, M.D.
IW49. Spiritual/Religious Assessment in Clinical Work Co-Chairpersons: Francis G. Lu, M.D., and Christina M. Puchalski, M.D.
IW50. When Psychiatrists Live With Mental Illness National Alliance on Mental Illness Co-Chairpersons: Michael F. Myers, M.D., and Leah J. Dickstein, M.D.
IW51. Ethical Dilemmas in Treating the Homeless Mentally Ill Co-Chairpersons: David M. Band, M.D., and Stephen M. Goldfinger, M.D.
IW52. The Psychiatrist and Parkinson’s Disease Co-Chairpersons: David M. Roane, M.D., and John D. Rogers, M.D.
IW53. Biobehavioral Treatment of Addictive Disorders Chairperson: Richard J. Frances, M.D.
IW54. The Media and Reaching Out to the Underserved Co-Chairpersons: Gabriela Cora-Locatelli, M.D., and Elmer E. Huerta, M.D.
IW55. Death in the Family: Family Tradition and the Will Chairperson: Gerald Schneiderman, M.D.
IW56. Is Retraining for Clinicians Necessary? Co-Chairpersons: Daniel Castellanos, M.D., and Sanford I. Cohen, M.D.
Noon-1:30 p.m.
Forums
5. Hate for Loving: How Societal Oppression Impacts Lesbian and Gay Mental Health Chairperson: Daniel W. Hicks, M.D.
6. Update on the Practice Guideline for the Treatment of Patients With BPD APA Steering Committee on Practice Guidelines Co-Chairpersons: John S. McIntyre, M.D., and Deborah A. Zarin, M.D.
7. Managing the Process of Change: Quality, Financing, and Patients’ Rights Chairperson: Eliot Sorel, M.D.
Noon-2 p.m.
New Research Poster Session
12:30 p.m.-2 p.m.
Media Session
Session 27. Jazz Alive!
45. Robert Altman’s Jazz 34: Remembrances of Kansas City Swing
1 p.m.-5 p.m.
CME Courses 87-92
2 p.m.-3:30 p.m.
Lectures
L18. Personality Disorders Are Personality Disorders Juan J. Lopez-Ibor Jr., Ph.D., International Psychiatrist Lecture Series
L19. The Persistent Neurobiological Consequences of Early Untoward Life Events: Treatment Implications Charles B. Nemeroff, M.D., Distinguished Psychiatrist Lecture Series
2 p.m.-5 p.m.
Media Sessions
Session 28. The Physically Challenged: Social and Longitudinal Perspectives
46. My Country
47. Best Man: “Best Boy” and All of Us 20 Years Later
Session 29. Creating Consumerism: How Advertising Shares Our Reality
48. The Ad and the Ego
49. Barbie Nation
Symposia
S45. Eating Disorders: Origins, Treatments, and Outcomes
A. The Genetics of Anorexia Nervosa: New Findings Walter H. Kaye, M.D.
B. Bulimics With Substance Use Disorders Marcia E. Rorty, Ph.D.
C. Anorexia Nervosa: Prevention of Relapse Katherine A. Halmi, M.D.
D. Treatment of Bulimia Nervosa Patients Who Do Not Respond to Cognitive-Behavior Therapy James E. Mitchell, M.D.
E. Treatment and Relapse in Eating Disorders David B. Herzog, M.D.
S46. Bipolar Disorder: From Research to the Complexities of Clinical Care
A. Recent Genetic Findings in Bipolar Disorder John I. Nurnberger Jr., M.D.
B. What Do Animal Models Tell Us About Bipolar Disorder? Aimee R. Mayeda, M.D.
C. Spectrum of Mixed States: With Mania and Hypomania Hagop S. Akiskal, M.D.
D. Ethnicity and Treatment of Bipolar Disorder William B. Lawson, M.D.
E. Challenges in Treating Women With Bipolar Disorder Katherine L. Wisner, M.D.
S47. New Insights Into Treating Postpartum Depression
A. Postpartum Anxiety and Mood Disorders: Effect on Infant Development Deirdre M. Ryan, M.B.
B. Paroxetine Levels in Mother/Infant Dyad Shaila Misri, M.D.
C. Medications During Pregnancy and Lactation: Defining Exposure Zachary N. Stowe, M.D.
D. Men Construct Fatherhood by Trial and Error: A Chilean and Canadian Study Susanne I. Steinberg, M.D.
E. Sleep Deprivation in Pregnancy and Postpartum Depression Barbara L. Parry, M.D.
S48. Physician-Assisted Suicide: A Look to the Future
A. Aggressive Management of the Terminally Ill Richard Whittingon, M.D.
B. Assisted Suicide: Physicians’ Attitudes Samuel I. Greenberg, M.D.
C. Psychological Benefits of an Assisted Death Faye Girsh, Ed.D.
D. Legal and Ethical Issues Ross A. McElroy Jr., M.D.
S49. Cultural Issues for Psychiatrists and Patients
A. Gender as a Cultural Issue Leah J. Dickstein, M.D.
B. Back-Drop Culture and Latinos: Clinical Impact Silvia W. Olarte, M.D.
C. Gay Men and Lesbians: Culture Based on Social Stigma Robert P. Cabaj, M.D.
D. Clinical Work With African-American Women Marilyn L. Martin, M.D.
E. Psychiatric Diagnosis in American Indians Ilena M. Norton, M.D.
S50. Thyroid Hormone: Neurobiology
A. CSF and Serum Iodothyronine in Depression Mark A. Frye, M.D.
B. The Use of Thyroid Hormones to Diminish the Cognitive Side Effects of Psychiatric Treatments Robert A. Stern, Ph.D.
C. T3 Acceleration Trials in Major Depression Lori L. Altshuler, M.D.
D. Adjunctive High-Dose Levothyroxine in Refractory Mood Disorders Michael Bauer, M.D.
S51. Impact of Parity and Managed Care on Mental Health Care
A. The Cost of Mental Health Insurance Parity Darrel A. Regier, M.D.
B. Access to Managed Mental Health Services and Cost: Is There a Trade-Off? Ellen M. Weissman, M.D.
C. Assessment of Quality in Managed Mental Health Services Stuart M. Sotsky, M.D.
D. Financial Incentives in Managed Behavioral Health Care Plans Agnes Rupp, Ph.D.
E. New Perspectives on Mental Health Treatment Needs William E. Narrow, M.D.
S52. Negative Symptoms: Beyond Schizophrenia
A. Characterization and Treatment of Negative Symptoms in Nonschizophrenia Patients Igor I. Galynker, M.D.
B. The Relationship of Negative Symptoms to Depression and Function in Dementia William E. Reichman, M.D.
C. Negative Symptoms in Frontotemporal Dementia Bruce L. Miller, M.D.
D. Negative Symptoms: Principal Component Analyses of Psychometric Scales in Nonschizophrenia Patients Alexander Prikhojan, M.D.
S53. Biological Dimensions of Psychotherapy APA Commission on Psychotherapy by Psychiatrists
A. It’s Not You, It’s Your Brain: Biology Talk in Therapy Charles A. Morgan III, M.D.
B. Toward a Biology of Cognitive-Behavior Therapy Michael E. Thase, M.D.
C. Potential Physiological Effects of the Psychotherapies Molyn Leszcz, M.D.
D. Neurobiology of Language in Psychotherapy William H. Sledge, M.D.
E. Genetics, Transference, and Psychic Representation David Reiss, M.D.
S54. Optimizing the Administration of ECT
A. Resolving the Controversy Between Unilateral and Bilateral ECT: Optimization of ECT Harold A. Sackeim, Ph.D.
B. Comparison of Fixed Versus Titrated Dose in Right Unilateral ECT W. Vaughn McCall, M.D.
C. Optimizing ECT in Patients With Very High Seizure Thresholds and Those Taking Benzodiazepines Richard D. Weiner, M.D.
D. The Role of Ictal EEG Data in Optimizing ECT Treatment Andrew D. Krystal, M.D.
S55. Pediatric Psychopharmacology
A. Effects of Long-Term Treatment With Stimulants in Children With ADHD: Findings From Three Randomized Clinical Trials Howard Abikoff, Ph.D.
B. A Randomized Controlled Trial of Lithium Prophylaxis in Adolescent Bipolar Disorder Neal D. Ryan, M.D.
C. OCD Multisite Treatment Studies John S. March, M.D.
D. A Multisite Treatment of Anxiety Disorders Laurence L. Greenhill, M.D.
E. Psychopharmacology of Autism Christopher J. McDougle, M.D.
F. Treatment of Adolescents With Depression: Research Perspectives Benedetto Vitiello, M.D.
S56. Aging of Patients With Schizophrenia
A. Schizophrenia and Aging: Myths and Reality Dilip V. Jeste, M.D.
B. Psychosocial Functioning of Older Persons With Schizophrenia Carl I. Cohen, M.D.
C. Cognition in Older Patients With Schizophrenia Richard Mohs, Ph.D.
D. Long-Term Outcome of Late-Life Schizophrenia Peter V. Rabins, M.D.
E. Management of Late-Life Schizophrenia Murray A. Raskind, M.D.
S57. Cultural Factors in Severe Mental Disorders Collaborative Session With the National Institute of Mental Health
A. The Mental Health of Immigrant and Refugee Children Peter J. Guarnaccia, Ph.D.
B. Culture, Gender, and Schizophrenia Among United States Latinas Janis H. Jenkins, Ph.D.
C. Culture, Ethnicity, and the Biopsychosocial Tradition Keh-Ming Lin, M.D.
D. Culture, Gender, and Diagnosis of Psychiatric Disorder Delores Parron, Ph.D.
S58. Gender: What’s the Difference?
A. Unraveling the Mysteries: Gender-Based Research Florence Haseltine, M.D.
B. Clinical Implications of Gender-Based Research: Lessons From Women Veterans Marian I. Butterfield, M.D.
C. Importance of Gender Analysis of Pharmaceuticals Freda C. Lewis-Hall, M.D.
D. The Public Health Service’s Commitment to Women’s Mental Health Wanda Jones, Dr.P.H.
E. The Congressional Response to Women’s Health Issues The Honorable Nita Lowey
S59. The Clinical Internet: American and European Experiences
A. Internet Jungle: Hunting for Patients’ Real Advantages Sergio De Risio, M.D.
B. Clinical Uses of the Internet: Promise, Problems, and Perils Ronald W. Pies, M.D.
C. Clinical Uses of the Internet: Some Suggestions Robert C. Hsiung, M.D.
D. Psychotherapy on the Internet Russell F. Lim, M.D.
E. Intranet for Management and Clinical Information Systems Professor P.M. Furlan, M.D.
S60. Science-Based Behavioral Therapies for Cocaine Addiction The National Institute on Drug Abuse
A. A Cognitive-Behavioral Approach to Treating Cocaine Addiction Kathleen M. Carroll, Ph.D.
B. Community Reinforcement Approach to Treatment Stephen T. Higgins, Ph.D.
C. Individual Counseling for Cocaine Addiction Delinda Mercer, Ph.D.
D. Relapse Prevention and Contingency Management of Cocaine Abuse Richard A. Rawson, M.D.
S61. Practicing Evidence-Based Psychiatry: Bipolar Disorder
A. Use of Formal Measures in Clinical Care Jacqueline Samson, Ph.D.
B. Clinical Practice Guidelines for Treatment Robert M.A. Hirschfeld, M.D.
C. What’s Really Going On in the Treatment of Bipolar Disorder? Deborah A. Zarin, M.D.
S62. BDD: New Research Findings for Clinical Practice
A. Clinical Features of BDD: Diagnosing an Underrecognized Disorder Katharine A. Phillips, M.D.
B. Pharmacological Treatment of BDD Eric Hollander, M.D.
C. Cognitive-Behavior Therapy for BDD David Veale, M.D.
D. BDD in Children and Adolescents Ralph S. Albertini, M.D.
E. BDD With Major Depression Andrew A. Nierenberg, M.D.
S63. Short-Term Stability of Personality Disorders
A. Short-Term Stability of Personality Disorder Diagnoses M. Tracie Shea, Ph.D.
B. Stability of Five-Factor Traits in Personality Disorder Leslie C. Morey, Ph.D.
C. Six-Month Stability of Axis I With Personality Disorder Comorbidity Thomas H. McGlashan, M.D.
D. Stability of Psychosocial Functioning in Personality Disorders Andrew E. Skodol II, M.D.
E. Continuity of Treatment for Patients With Personality Disorders Donna S. Bender, Ph.D.
S64. The Evolution of Community Psychiatry in Italy
A. Standardized Assessment of Psychiatric Care in Italy Carmine Munizza, M.D.
B. The Organization of Community Psychiatry: Other than Rehabilitation Bruno Commodari, M.D.
C. Therapeutic Program Integrated With the Community Psychiatry Facilities and the Functions of the Mental Health Department Vincenzo Gatti, M.D.
D. Residency in a Community Psychiatry Program Without a Mental Hospital Luigi Ferrannini, M.D.
E. The Long-Term Treatment of Schizophrenia: The Opinions of the Italian Psychiatrists Mariano Bassi, M.D.
F. From Informed Consent to Contract in the Practice of Italian Community Psychiatry Claudio Mencacci, M.D.
G. The Noncompliance Problem in Schizophrenia and Psychoeducational Intervention: The Prelapse Italian Project Mariano Bassi, M.D.
S65. Relapse in Co-Occurring Disorders The Substance Abuse and Mental Health Services Administration of the Department of Health and Human Services
A. Epidemiology of Dual Disorders Bert Pepper, M.D.
B. Systems Approach in Co-Occurring Disorders Michael English, Ph.D.
C. Relapse to Forensic Settings Raymond F. Patterson, M.D.
D. Relapse to Homelessness Walter Leginski, Ph.D.
E. Relapse Into Institutional and Emergency Care Settings Roger Peele, M.D.
2 p.m.-5:30 p.m.
Review of Psychiatry, Part V: Schizophrenia in a Molecular Age Chairperson: Carol A. Tamminga, M.D.
21. The Multidimensional Phenotype of Schizophrenia Peter F. Liddle, M.D.
22. The Implications of Early Sensory Processing and Subcortical Involvement for Cognitive Dysfunction in Schizophrenia John Gruzelier, Ph.D.
23. Disruption of Information Flow Within Cortical-Limbic-Circuits and the Pathophysiology of Schizophrenia Anthony A. Grace, Ph.D.
24. Functional Neuroimaging Applied to the Syndrome of Schizophrenia: Symptom, Treatment, and Etiologic Observations Henry H. Holcomb, M.D.
25. Molecular Biology and Antipsychotic Medications S. Charles Schulz, M.D.
7 p.m.-10 p.m.
Industry-Supported Symposia
IS35. The Interface Between Depression and Dementia Supported by Parke-Davis
A. Clinical Assessment: Mood, Cognition and Their Interaction in the Elderly David L. Sultzer, M.D.
B. Depressed Mood and Dementia in Elderly Patients in the Community Davangere P. Devanand, M.D.
C. Treatment of Depression in the Old-Old Steven P. Roose, M.D.
D. Pharmacotherapy of the Cognitively Impaired Bruce G. Pollock, M.D.
E. Cardiovascular Changes in Depression and Dementia K. Ranga R. Krishnan, M.D.
IS36. Antidepressant Combinations for Drug-Resistant and Intolerant Cases Supported by Wyeth-Ayerst Laboratories
A. Cellular Mechanisms of Antidepressant Action Richard C. Shelton, M.D.
B. How to Combine Two Antidepressants for Treatment Synergy and Side-Effect Reductions Stephen M. Stahl, M.D.
C. When Is Polypharmacy Good in Treating Major Depression? Jeffrey E. Kelsey, M.D.
IS37. Recent Advances in Psychopharmacology American Society of Clinical Psychopharmacology Supported by Bristol-Myers Squibb
A. New Treatments for Schizophrenia Stephen R. Marder, M.D.
B. New Treatments for Bipolar Disorder Lori L. Altshuler, M.D.
C. Removing the Chronicity From Chronic Depression James H. Kocsis, M.D.
D. Treatment of Comorbid Anxiety and Substance Abuse Kathleen T. Brady, M.D.
E. Drug Interactions: A Practical Primer for Clinicians James W. Jefferson, M.D.
IS38. Treating Depression: Effectivness Without Extravagance Supported by Healthcare Technology Systems
A. The Burden of Untreated Depressions Ronald C. Kessler, Ph.D.
B. Can Primary Care Deliver Quality Treatment of Depression? Elizabeth H.B. Lin, M.D.
C. Clinical Outcomes CARE Study David J. Katzelnick, M.D.
D. Cost-Effectiveness of Depression Treatment Programs Gregory E. Simon, M.D.
E. “Dividing the Pie” Between Primary Care Physicians and Psychiatrists Jonathan F. Borus, M.D.
IS39. Time and Depression Supported by Organon Inc.
A. Depressive Spectrum Disorder and Treatment Mark H. Rapaport, M.D.
B. Depressed Children: Growing and Grown Up Neal D. Ryan, M.D.
C. When Do Depressed Patients Start to Respond to Antidepressants? Alan J. Gelenberg, M.D.
D. Personality and Depression Over Time M. Tracie Shea, Ph.D.
E. Residual Symptoms After Response to Antidepressants Andrew A. Nierenberg, M.D.
IS40. Norepinephrine: Neurotransmitter for the Millennium Supported by Pharmacia & Upjohn Company Inc.
A. Problems With Currently Available Antidepressants Charles B. Nemeroff, M.D.
B. Norepinephrine Involvement in Antidepressant Action Alan Frazer, Ph.D.
C. Norepinephrine Dysfunction in Depression Dennis S. Charney, M.D.
D. Clinical Efficacy of Reboxetine in Major Depression Alan F. Schatzberg, M.D.
E. Genetic Ablation of the Norepinephrine Transporter in Mice Marc G. Caron, Ph.D.
Media Sessions
Session 30. Ethnic Hate Crimes: Psychiatric Implications
50. Letters to Thien
51. Forgotten Fires
Session 31. Exploring Hasidism: A Life Apart: Hasidism in America Mesorah Society for Traditional Judaism and Psychiatry
52. A Life Apart: Hasidism in America
Symposia
S66. Sexual Behavior and Substance Use Research With the Mentally Ill
A. HIV Risk Behavior Among Outpatients at a State Psychiatric Hospital Michael P. Carey, Ph.D.
B. Outcomes of HIV Prevention Interventions Integrated in Community Clinics That Serve Persons With Severe Mental Illness Jeffrey A. Kelly, Ph.D.
C. Clinical Trials of Ethnographically Based Interventions Ezra S. Susser, M.D.
D. Adherence to TB and HIV Drug Regimens Among Marginalized People Andrew Moss, Ph.D.
S67. Psychiatric Disorders in a Special Population: The Athlete International Society for Sport Psychiatry
A. Pathological Body Image in the Athletic Arena Antonia L. Baum, M.D.
B. Anorexia Athletica and Other Atypical Eating Disorders Robert W. Burton, M.D.
C. Treatment to Keep Athletes Functioning Ira D. Glick, M.D.
S68. Eye Movement Desensitization and Reprocessing (EMDR)
A. EMDR: Information Processing Therapy for Trauma Francine Shapiro, Ph.D.
B. EMDR Treatment for Children With Disaster-Related PTSD Claude M. Chemtob, Ph.D.
C. Neurobiological Dimensions of EMDR: Physiology and Neuroimaging Bessel A. van der Kolk, M.D.
D. Using EMDR in Complex PTSD and Adult Attachment Disorders Andrew M. Leeds, Ph.D.
69. Music Therapy in Psychosocial Care and Pain Management
A. Music Therapy: An Overview John S. McIntyre, M.D.
B. Music Therapy and Pain Management Joanne V. Loewy, D.A.
C. Music Therapy, Assisted Labor, and Delivery Bryan C. Hunter, Ph.D.
D. Creative Music Therapy: Accessing the Healthy Care Kenneth S. Aigen, D.A.
E. Beyond the Sing-Along: Current Trends in Music Therapy Research and Practice With Older Adults Anne W. Lipe, Ph.D.
S70. New World Psychiatric Association Initiatives on Education World Psychiatric Association
A. Educational Structures of the World Psychiatric Association Roger M. Montenegro, M.D.
B. International Guidelines for Diagnostic Assessment Juan E. Mezzich, M.D.
C. Core Curriculum in Psychiatry for Medical Students Ahmed M.F. Okasha, M.D.
D. Teaching About Public Health Aspects of Psychiatry Norman Sartorius, M.D.
S71. Strategies for Selecting an Antidepressant Medication
A. Mechanism of Action of Antidepressants Alan Frazer, Ph.D.
B. Clinical Symptoms and Antidepressant Mechanism of Action: Any Relation? Robert M.A. Hirschfeld, M.D.
C. Age-Related Differences in Medication Response Ian A. Cook, M.D.
D. Improvements in Social Functioning With Antidepressant Treatment Martha L. Bruce, Ph.D.
E. Brain Function and Selection of Antidepressant Medication Andrew F. Leuchter, M.D.